Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Emodin
Cat. No.:
OB0425LY-393
Appearance:
Solid
Purity:
98.95%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
Emodin is an an anthraquinone derivative with anti-inflammatory and anticancer effects. It also inhibits casein kinase-2.
Synonyms:
518-82-1; Emodol; Frangula emodin; Schuttgelb; 1,3,8-Trihydroxy-6-methylanthracene-9,10-dione; Rheum emodin; Archin; Frangulic acid; 3-Methyl-1,6,8-trihydroxyanthraquinone
CAS No.:
518-82-1
Compound CID:
3220
Formula:
C15H10O5
Formula Weight:
270.24
Specification
Target:
Casein kinase; Autophagy; SARS-CoV; 11β-HSD
Pathway:
Cell cycle/DNA damage; Stem cell/Wnt; Autophagy; Anti-infection; Metabolic enzyme/Protease
Solubility:
DMSO, Acetone
Storage:
Storage at -20°C.
Applications:
Emodin can be used to study metabolic disorders in diet-induced obese mice.
